Verastem, Inc. (VSTM)
10.01
-0.11
(-1.09%)
USD |
NASDAQ |
Dec 10, 16:00
9.995
-0.02
(-0.15%)
Pre-Market: 20:00
Verastem Research and Development Expense (TTM): 103.74M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| CorMedix, Inc. | 12.46M |
| Anavex Life Sciences Corp. | 37.59M |
| Ocugen, Inc. | 35.49M |
| Syndax Pharmaceuticals, Inc. | 245.67M |
| AnaptysBio, Inc. | 152.43M |